FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3107173713> ?p ?o ?g. }

• W3107173713 abstract "Abstract Background Cardiopulmonary bypass (CPB) is an important cause of significant systemic inflammatory response syndrome (SIRS) in the surgical treatment of acute type A aortic dissection (ATAAD). In patients with arch vessel involvement, extensive surgical repairs often necessitate prolonged use of CPB and results in extensive inflammatory responses. Cytokines and chemokines released during CPB contribute to the progression of SIRS, increase perioperative complications, and negatively impact surgical outcomes. A cytokine adsorber (HA380) is expected to reduce the level of cytokines during CPB, which may decrease both intraoperative and postoperative inflammation. The purpose of this study is to investigate if HA380 is able to reduce the levels of inflammatory cytokines and decrease perioperative complications in ATAAD patients undergoing CPB and deep hypothermic circulatory arrest (DHCA). Methods This study is a single-center, randomized, controlled, double-blind clinical trial. The study aims to recruit 88 patients with ATAAD and aortic arch involvement who will undergo CPB and DHCA to repair the dissected aorta. Patients will be randomized equally into the CPB/DHCA only group (control group) and the CPB/DHCA + HA380 hemoperfusion group (intervention group), with 44 patients each. Patients in the control group will undergo CPB and DHCA only, while patients in the intervention group will undergo continuous hemoperfusion with HA380, in addition to CPB and DHCA. The primary outcome is a composite of major perioperative complications. The secondary outcomes include related inflammatory markers, coagulation parameters, and minor perioperative complications. To comprehensively evaluate the effect of hemoperfusion on the perioperative outcomes, we will also determine if there are differences in perioperative all-cause mortality, length of ICU stay, and total hospitalization costs. Discussion In the current trial, hemoperfusion will be applied in patients undergoing CPB and DHCA for repair of the aorta involving the aortic arch. This trial aims to test the safety and efficacy of our hemoperfusion device (HA380) in such settings. Upon completion of the trial, we will determine if HA380 is effective in reducing perioperative proinflammatory cytokine levels. Further, we will also verify if reduction in the proinflammatory cytokine levels, if present, translates to improvement in patient outcomes. Trial registration ClinicalTrials.gov NCT04007484 . Registered on 1 July 2019 (retrospectively registered)." @default.
• W3107173713 created "2020-12-07" @default.
• W3107173713 creator A5006061787 @default.
• W3107173713 creator A5008295359 @default.
• W3107173713 creator A5011216849 @default.
• W3107173713 creator A5028392553 @default.
• W3107173713 creator A5040769958 @default.
• W3107173713 creator A5051828116 @default.
• W3107173713 creator A5065693501 @default.
• W3107173713 creator A5069883382 @default.
• W3107173713 creator A5070590692 @default.
• W3107173713 creator A5074780748 @default.
• W3107173713 creator A5088619837 @default.
• W3107173713 date "2020-11-23" @default.
• W3107173713 modified "2023-10-15" @default.
• W3107173713 title "Hemoperfusion with HA380 in acute type A aortic dissection patients undergoing aortic arch operation (HPAO): a randomized, controlled, double-blind clinical trial" @default.
• W3107173713 cites W1968847966 @default.
• W3107173713 cites W1982082299 @default.
• W3107173713 cites W1988702607 @default.
• W3107173713 cites W1989832114 @default.
• W3107173713 cites W2003156597 @default.
• W3107173713 cites W2014597111 @default.
• W3107173713 cites W2026274122 @default.
• W3107173713 cites W2030996635 @default.
• W3107173713 cites W2033196228 @default.
• W3107173713 cites W2037930718 @default.
• W3107173713 cites W2041617636 @default.
• W3107173713 cites W2055649989 @default.
• W3107173713 cites W2063328389 @default.
• W3107173713 cites W2084001707 @default.
• W3107173713 cites W2090951683 @default.
• W3107173713 cites W2150368848 @default.
• W3107173713 cites W2151351508 @default.
• W3107173713 cites W2159374684 @default.
• W3107173713 cites W2221074368 @default.
• W3107173713 cites W2235399809 @default.
• W3107173713 cites W2296564716 @default.
• W3107173713 cites W2328137612 @default.
• W3107173713 cites W2345461867 @default.
• W3107173713 cites W2567568104 @default.
• W3107173713 cites W2733170430 @default.
• W3107173713 cites W2766256658 @default.
• W3107173713 cites W2767324373 @default.
• W3107173713 cites W2804904325 @default.
• W3107173713 cites W2806817136 @default.
• W3107173713 cites W2807534719 @default.
• W3107173713 cites W2891013275 @default.
• W3107173713 cites W2909998886 @default.
• W3107173713 cites W2917268196 @default.
• W3107173713 cites W2938989086 @default.
• W3107173713 cites W2980819145 @default.
• W3107173713 cites W4238277289 @default.
• W3107173713 cites W4385437251 @default.
• W3107173713 doi "https://doi.org/10.1186/s13063-020-04858-2" @default.
• W3107173713 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7684885" @default.
• W3107173713 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33228727" @default.
• W3107173713 hasPublicationYear "2020" @default.
• W3107173713 type Work @default.
• W3107173713 sameAs 3107173713 @default.
• W3107173713 citedByCount "0" @default.
• W3107173713 crossrefType "journal-article" @default.
• W3107173713 hasAuthorship W3107173713A5006061787 @default.
• W3107173713 hasAuthorship W3107173713A5008295359 @default.
• W3107173713 hasAuthorship W3107173713A5011216849 @default.
• W3107173713 hasAuthorship W3107173713A5028392553 @default.
• W3107173713 hasAuthorship W3107173713A5040769958 @default.
• W3107173713 hasAuthorship W3107173713A5051828116 @default.
• W3107173713 hasAuthorship W3107173713A5065693501 @default.
• W3107173713 hasAuthorship W3107173713A5069883382 @default.
• W3107173713 hasAuthorship W3107173713A5070590692 @default.
• W3107173713 hasAuthorship W3107173713A5074780748 @default.
• W3107173713 hasAuthorship W3107173713A5088619837 @default.
• W3107173713 hasBestOaLocation W31071737131 @default.
• W3107173713 hasConcept C141071460 @default.
• W3107173713 hasConcept C154281038 @default.
• W3107173713 hasConcept C157767197 @default.
• W3107173713 hasConcept C168563851 @default.
• W3107173713 hasConcept C2778384902 @default.
• W3107173713 hasConcept C2778881276 @default.
• W3107173713 hasConcept C2779980429 @default.
• W3107173713 hasConcept C2779993142 @default.
• W3107173713 hasConcept C2780631194 @default.
• W3107173713 hasConcept C2781090800 @default.
• W3107173713 hasConcept C31174226 @default.
• W3107173713 hasConcept C42219234 @default.
• W3107173713 hasConcept C71924100 @default.
• W3107173713 hasConceptScore W3107173713C141071460 @default.
• W3107173713 hasConceptScore W3107173713C154281038 @default.
• W3107173713 hasConceptScore W3107173713C157767197 @default.
• W3107173713 hasConceptScore W3107173713C168563851 @default.
• W3107173713 hasConceptScore W3107173713C2778384902 @default.
• W3107173713 hasConceptScore W3107173713C2778881276 @default.
• W3107173713 hasConceptScore W3107173713C2779980429 @default.
• W3107173713 hasConceptScore W3107173713C2779993142 @default.
• W3107173713 hasConceptScore W3107173713C2780631194 @default.
• W3107173713 hasConceptScore W3107173713C2781090800 @default.
• W3107173713 hasConceptScore W3107173713C31174226 @default.
• W3107173713 hasConceptScore W3107173713C42219234 @default.
• W3107173713 hasConceptScore W3107173713C71924100 @default.
• W3107173713 hasFunder F4320321001 @default.

• next